Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenctomy have similar survival to stage I/II patients and superior survival to other stage III patients

Cancer

Volumn 83, Issue 8, 1998, Pages 1555-1560

  Onda, Takashi ^a   Yoshikawa, Hiroyuki ^a   Yasugi, Toshiharu ^a   Mishima, Misako ^a   Nakagawa, Shunsuke ^a   Yamada, Manabu ^a   Matsumoto, Koji ^a   Taketani, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Aortic and pelvic lymphadenectomy; Lymph node involvement; Ovarian carcinoma; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; METASTASIS; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AORTA; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PELVIS; PERITONEAL NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 0032531747     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19981015)83:8<1555::AID-CNCR10>3.0.CO;2-R     Document Type: Article

References (20)

1. Knapp RC, Friedman EA. Aortic lymph node metastases in early ovarian cancer. Am J Obstet Gynecol 1974;119:1013-7.
2. Burghardt E, Pickel H, Stettner H. Management of advanced ovarian cancer. Eur J Gynaecol Oncol 1984;3:155-9.
3. Chen SS. Survival of ovarian carcinoma with or without lymph node metastasis. Gynecol Oncol 1987;27:368-72.
4. DiRe F, Fontanelli R, Raspagliesi F, DiRe E. Pelvic and paraaortic lymphadenectomy in cancer of the ovary. Baillieres Clin Obstet Gynaecol 1989;3:131-42.
5. Wu PC, Lang JH, Huang RL, Qu JY, Wang H, Tang MY, et al. Lymph node metastasis and retroperitoneal lymphadenectomy in ovarian cancer. Baillieres Clin Obstet Gynaecol 1989; 3:143-55.
6. Sakai K, Kamura T, Hirakawa T, Saito T, Kaku T, Nakano H. Relationship between pelvic lymph node involvement and other disease site in patients with ovarian cancer. Gynecol Oncol 1997;65:164-8.
7. Scarabelli C, Gallo A, Zarrelli A, Visentin C, Campagnutta E. Systematic pelvic and para-aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival. Gynecol Oncol 1995;56:328-37.
8. Spirtos NM, Gross GM, Freddo JL, Ballon SC. Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy. Gynecol Oncol 1995;56:345-52.
9. The Oncology Committee of the International Federation of Gynecologists and Obstetricians. FIGO news: changes to the 1985 FIGO report on the result of treatment in gynecological cancer, Int J Gynecol Obstet 1987;25:87-8.
10. Chen SS, Lee L. Incidence of para-aortic and pelvic lymph node metastases in epithelial carcinoma of the ovary. Gynecol Oncol 1983;16:95-100.
11. Wu PC, Qu JY, Lang JH, Huang RL, Tang MY, Lian LJ. Lymph node metastasis of ovarian cancer: a preliminary survey of 74 cases of lymphadenectomy. Am J Obstet Gynecol 1986; 155:1103-8.
12. Pickel H, Lahousen M, Stettner H, Girardi F. The spread of ovarian cancer. Baillieres Clin Obstet Gynaecol 1989;3:3-12.
13. Burghardt E, Girardi F, Lahousen M, Tamussino K, Stettner H. Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol 1991;40:103-6.
14. DiRe F, Baiocchi G, Fontanelli R, Grosso G, Cobellis L, Raspagliesi F, et al. Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: prognostic significance of node metastases. Gynecol Oncol 1996;62:360-5.
15. Onda T, Yoshikawa H, Yokota H, Yasugi T, Taketani Y. Assessment of metastases to aortic and pelvic lymph nodes in ovarian carcinoma: a proposal for essential site for lymph node biopsy. Cancer 1996;78:803-8.
16. Lanza A, D'Addato F, Valli M, Bussone R, Caldarola B, Re A, et al. Pelvic and para-aortic lymph nodal positivity in the ovarian carcinoma: its prognostic significance. Eur J Gynaecol Oncol 1988;9:36-9.
17. Carnino F, Fuda G, Ciccone G, Iskra L, Guercio E, Dadone D, et al. Significance of lymph node sampling in epithelial carcinoma of the ovary. Gynecol Oncol 1997;65:467-72.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
19. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
20. Petru E, Lahousen M, Tamussino K, Pickel H, Stranzl H, Stettner H, et al. Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 1994;170:656-62.